aluates Reports

$ 0.0

Automative

Global Drug Repositioning Market Research Report 2026

Published Date: 2026-04-13

Report Code: QYRE-Auto-16V9136

Global Drug Repositioning Market Size Status and Forecast 2022

BUY CHAPTERS

Global Drug Repositioning Market Research Report 2026

Code: QYRE-Auto-16V9136

Report

2026-04-13

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Johnson & Johnson

Bausch Health

GSK

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Pfizer Inc

TEVA

Mylan NV

Johnson & Johnson

Drug Repositioning Market Size

The global Drug Repositioning market was valued at US$ 30990 million in 2025 and is anticipated to reach US$ 42560 million by 2032, at a CAGR of 4.7% from 2026 to 2032.

Drug Repositioning Market

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

The drug repositioning market is driven by the growing demand for cost-effective and time-saving drug development strategies. Traditional drug discovery can take over a decade and cost billions of dollars, with a high risk of failure during clinical trials. Repositioning, on the other hand, allows pharmaceutical companies to repurpose known drugs with existing safety and pharmacokinetic profiles, thereby accelerating time to market and reducing development risk. This approach is especially appealing for rare diseases, cancer, and neurodegenerative disorders where treatment options are limited. Additionally, advances in data mining, artificial intelligence, and systems biology have improved the ability to identify new drug-disease relationships, fueling further interest. Regulatory agencies such as the FDA and EMA also support repositioning by offering faster review pathways and incentives for orphan indications, making this strategy increasingly viable from a business perspective.

Despite its advantages, the drug repositioning market faces several challenges. One of the major issues is intellectual property protection—many repositioned drugs are off-patent, making it difficult for companies to secure exclusivity and justify investment. In cases where patent life can be extended through new formulations or uses, legal and regulatory hurdles still exist. Another challenge lies in clinical validation; while safety data may already be available, proving efficacy for a new indication still requires substantial clinical trial investment. Moreover, the lack of centralized, standardized databases for repositioning candidates limits discovery efficiency. The fragmented nature of available data—spread across academic publications, clinical trial registries, and real-world evidence—makes it hard to integrate and analyze comprehensively. Finally, collaboration between industry and academia, which is crucial for repositioning, is often hindered by misaligned goals and timelines.

This report delivers a comprehensive overview of the global Drug Repositioning market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Repositioning. The Drug Repositioning market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drug Repositioning market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drug Repositioning manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drug Repositioning Market Report

Report Metric	Details
Report Name	Drug Repositioning Market
Accounted market size in 2025	US$ 30990 million
Forecasted market size in 2032	US$ 42560 million
CAGR	4.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Generic Drugs Clinical Trial Failed Drugs
Segment by Application	Cardiovascular Diseases Mental Illness Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug Repositioning companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Drug Repositioning Market growing?

Ans: The Drug Repositioning Market witnessing a CAGR of 4.7% during the forecast period 2026-2032.

What is the Drug Repositioning Market size in 2032?

Ans: The Drug Repositioning Market size in 2032 will be US$ 42560 million.

Who are the main players in the Drug Repositioning Market report?

Ans: The main players in the Drug Repositioning Market are Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma

What are the Application segmentation covered in the Drug Repositioning Market report?

Ans: The Applications covered in the Drug Repositioning Market report are Cardiovascular Diseases, Mental Illness, Cancer, Others

What are the Type segmentation covered in the Drug Repositioning Market report?

Ans: The Types covered in the Drug Repositioning Market report are Generic Drugs, Clinical Trial Failed Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Generic Drugs

1.2.3 Clinical Trial Failed Drugs

1.3 Market by Application

1.3.1 Global Drug Repositioning Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Cardiovascular Diseases

1.3.3 Mental Illness

1.3.4 Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Repositioning Market Perspective (2021–2032)

2.2 Global Drug Repositioning Growth Trends by Region

2.2.1 Global Drug Repositioning Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Drug Repositioning Historic Market Size by Region (2021–2026)

2.2.3 Drug Repositioning Forecasted Market Size by Region (2027–2032)

2.3 Drug Repositioning Market Dynamics

2.3.1 Drug Repositioning Industry Trends

2.3.2 Drug Repositioning Market Drivers

2.3.3 Drug Repositioning Market Challenges

2.3.4 Drug Repositioning Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Repositioning Players by Revenue

3.1.1 Global Top Drug Repositioning Players by Revenue (2021–2026)

3.1.2 Global Drug Repositioning Revenue Market Share by Players (2021–2026)

3.2 Global Top Drug Repositioning Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Drug Repositioning Revenue

3.4 Global Drug Repositioning Market Concentration Ratio

3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2025

3.5 Global Key Players of Drug Repositioning Head Offices and Areas Served

3.6 Global Key Players of Drug Repositioning, Products and Applications

3.7 Global Key Players of Drug Repositioning, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Drug Repositioning Breakdown Data by Type

4.1 Global Drug Repositioning Historic Market Size by Type (2021–2026)

4.2 Global Drug Repositioning Forecasted Market Size by Type (2027–2032)

5 Drug Repositioning Breakdown Data by Application

5.1 Global Drug Repositioning Historic Market Size by Application (2021–2026)

5.2 Global Drug Repositioning Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Drug Repositioning Market Size (2021–2032)

6.2 North America Drug Repositioning Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Drug Repositioning Market Size by Country (2021–2026)

6.4 North America Drug Repositioning Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Repositioning Market Size (2021–2032)

7.2 Europe Drug Repositioning Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Drug Repositioning Market Size by Country (2021–2026)

7.4 Europe Drug Repositioning Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Drug Repositioning Market Size (2021–2032)

8.2 Asia-Pacific Drug Repositioning Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Drug Repositioning Market Size by Region (2021–2026)

8.4 Asia-Pacific Drug Repositioning Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Drug Repositioning Market Size (2021–2032)

9.2 Latin America Drug Repositioning Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Drug Repositioning Market Size by Country (2021–2026)

9.4 Latin America Drug Repositioning Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Repositioning Market Size (2021–2032)

10.2 Middle East & Africa Drug Repositioning Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Drug Repositioning Market Size by Country (2021–2026)

10.4 Middle East & Africa Drug Repositioning Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Drug Repositioning Introduction

11.1.4 Teva Revenue in Drug Repositioning Business (2021–2026)

11.1.5 Teva Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Drug Repositioning Introduction

11.2.4 Novartis Revenue in Drug Repositioning Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Mylan

11.3.1 Mylan Company Details

11.3.2 Mylan Business Overview

11.3.3 Mylan Drug Repositioning Introduction

11.3.4 Mylan Revenue in Drug Repositioning Business (2021–2026)

11.3.5 Mylan Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Drug Repositioning Introduction

11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2021–2026)

11.4.5 Johnson & Johnson Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Drug Repositioning Introduction

11.5.4 Pfizer Revenue in Drug Repositioning Business (2021–2026)

11.5.5 Pfizer Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Details

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Drug Repositioning Introduction

11.6.4 Bausch Health Revenue in Drug Repositioning Business (2021–2026)

11.6.5 Bausch Health Recent Development

11.7 GSK

11.7.1 GSK Company Details

11.7.2 GSK Business Overview

11.7.3 GSK Drug Repositioning Introduction

11.7.4 GSK Revenue in Drug Repositioning Business (2021–2026)

11.7.5 GSK Recent Development

11.8 ChemRar Group

11.8.1 ChemRar Group Company Details

11.8.2 ChemRar Group Business Overview

11.8.3 ChemRar Group Drug Repositioning Introduction

11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2021–2026)

11.8.5 ChemRar Group Recent Development

11.9 Glenmark

11.9.1 Glenmark Company Details

11.9.2 Glenmark Business Overview

11.9.3 Glenmark Drug Repositioning Introduction

11.9.4 Glenmark Revenue in Drug Repositioning Business (2021–2026)

11.9.5 Glenmark Recent Development

11.10 Fujifilm

11.10.1 Fujifilm Company Details

11.10.2 Fujifilm Business Overview

11.10.3 Fujifilm Drug Repositioning Introduction

11.10.4 Fujifilm Revenue in Drug Repositioning Business (2021–2026)

11.10.5 Fujifilm Recent Development

11.11 Dr. Reddy

11.11.1 Dr. Reddy Company Details

11.11.2 Dr. Reddy Business Overview

11.11.3 Dr. Reddy Drug Repositioning Introduction

11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2021–2026)

11.11.5 Dr. Reddy Recent Development

11.12 R-Pharma

11.12.1 R-Pharma Company Details

11.12.2 R-Pharma Business Overview

11.12.3 R-Pharma Drug Repositioning Introduction

11.12.4 R-Pharma Revenue in Drug Repositioning Business (2021–2026)

11.12.5 R-Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Johnson & Johnson

Bausch Health

GSK

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Pfizer Inc

TEVA

Mylan NV

Johnson & Johnson

List of Tables

Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Generic Drugs

Table 3. Key Players of Clinical Trial Failed Drugs

Table 4. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Drug Repositioning Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Drug Repositioning Market Size by Region (US$ Million), 2021–2026

Table 7. Global Drug Repositioning Market Share by Region (2021–2026)

Table 8. Global Drug Repositioning Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Drug Repositioning Market Share by Region (2027–2032)

Table 10. Drug Repositioning Market Trends

Table 11. Drug Repositioning Market Drivers

Table 12. Drug Repositioning Market Challenges

Table 13. Drug Repositioning Market Restraints

Table 14. Global Drug Repositioning Revenue by Players (US$ Million), 2021–2026

Table 15. Global Drug Repositioning Market Share by Players (2021–2026)

Table 16. Global Top Drug Repositioning Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug Repositioning Revenue, 2025

Table 17. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Drug Repositioning, Headquarters and Area Served

Table 20. Global Key Players of Drug Repositioning, Products and Applications

Table 21. Global Key Players of Drug Repositioning, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Drug Repositioning Market Size by Type (US$ Million), 2021–2026

Table 24. Global Drug Repositioning Revenue Market Share by Type (2021–2026)

Table 25. Global Drug Repositioning Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Drug Repositioning Revenue Market Share by Type (2027–2032)

Table 27. Global Drug Repositioning Market Size by Application (US$ Million), 2021–2026

Table 28. Global Drug Repositioning Revenue Market Share by Application (2021–2026)

Table 29. Global Drug Repositioning Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Drug Repositioning Revenue Market Share by Application (2027–2032)

Table 31. North America Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Drug Repositioning Market Size by Country (US$ Million), 2021–2026

Table 33. North America Drug Repositioning Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Drug Repositioning Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Drug Repositioning Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Drug Repositioning Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Drug Repositioning Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Drug Repositioning Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Drug Repositioning Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Drug Repositioning Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Drug Repositioning Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Drug Repositioning Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Drug Repositioning Market Size by Country (US$ Million), 2027–2032

Table 46. Teva Company Details

Table 47. Teva Business Overview

Table 48. Teva Drug Repositioning Product

Table 49. Teva Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 50. Teva Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Drug Repositioning Product

Table 54. Novartis Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 55. Novartis Recent Development

Table 56. Mylan Company Details

Table 57. Mylan Business Overview

Table 58. Mylan Drug Repositioning Product

Table 59. Mylan Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 60. Mylan Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Drug Repositioning Product

Table 64. Johnson & Johnson Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 65. Johnson & Johnson Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Drug Repositioning Product

Table 69. Pfizer Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 70. Pfizer Recent Development

Table 71. Bausch Health Company Details

Table 72. Bausch Health Business Overview

Table 73. Bausch Health Drug Repositioning Product

Table 74. Bausch Health Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 75. Bausch Health Recent Development

Table 76. GSK Company Details

Table 77. GSK Business Overview

Table 78. GSK Drug Repositioning Product

Table 79. GSK Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 80. GSK Recent Development

Table 81. ChemRar Group Company Details

Table 82. ChemRar Group Business Overview

Table 83. ChemRar Group Drug Repositioning Product

Table 84. ChemRar Group Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 85. ChemRar Group Recent Development

Table 86. Glenmark Company Details

Table 87. Glenmark Business Overview

Table 88. Glenmark Drug Repositioning Product

Table 89. Glenmark Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 90. Glenmark Recent Development

Table 91. Fujifilm Company Details

Table 92. Fujifilm Business Overview

Table 93. Fujifilm Drug Repositioning Product

Table 94. Fujifilm Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 95. Fujifilm Recent Development

Table 96. Dr. Reddy Company Details

Table 97. Dr. Reddy Business Overview

Table 98. Dr. Reddy Drug Repositioning Product

Table 99. Dr. Reddy Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 100. Dr. Reddy Recent Development

Table 101. R-Pharma Company Details

Table 102. R-Pharma Business Overview

Table 103. R-Pharma Drug Repositioning Product

Table 104. R-Pharma Revenue in Drug Repositioning Business (US$ Million), 2021–2026

Table 105. R-Pharma Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Drug Repositioning Picture

Figure 2. Global Drug Repositioning Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Drug Repositioning Market Share by Type: 2025 vs 2032

Figure 4. Generic Drugs Features

Figure 5. Clinical Trial Failed Drugs Features

Figure 6. Global Drug Repositioning Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Drug Repositioning Market Share by Application: 2025 vs 2032

Figure 8. Cardiovascular Diseases Case Studies

Figure 9. Mental Illness Case Studies

Figure 10. Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. Drug Repositioning Report Years Considered

Figure 13. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Drug Repositioning Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Drug Repositioning Market Share by Region: 2025 vs 2032

Figure 16. Global Drug Repositioning Market Share by Players in 2025

Figure 17. Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2025

Figure 19. North America Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Drug Repositioning Market Share by Country (2021–2032)

Figure 21. United States Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Drug Repositioning Market Share by Country (2021–2032)

Figure 25. Germany Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Drug Repositioning Market Share by Region (2021–2032)

Figure 33. China Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Drug Repositioning Market Share by Country (2021–2032)

Figure 41. Mexico Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Drug Repositioning Market Share by Country (2021–2032)

Figure 45. Israel Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Drug Repositioning Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Teva Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 49. Novartis Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 50. Mylan Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 51. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 52. Pfizer Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 53. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 54. GSK Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 55. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 56. Glenmark Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 57. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 58. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 59. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Repurposed Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Repurposing Market Research Report 2024

Drug Reprofiling Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Repurposing Serveice Market Research Report 2025

Global Chemotherapy Drug Market Insights Forecast to 2030

Global Regenerative Drugs Market Insights Forecast to 2030

Outsourced Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030

Global Medication Management Market Insights Forecast to 2030

Drug Reconstitution System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Inventory Management Software Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs For Hormonal Replacement Market Insights Forecast to 2030

Global Innovative Drug Market Insights Forecast to 2030

Global Outsourcing in Drug Discovery Market Research Report 2024

Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030

Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030

Global Drug Discovery Software Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions